USP8 and neoplasm: Moreover, to further confirm that CD8 + T cells were the mediators of anti-tumor immunity, we depleted CD8 + T cells prior to inoculation with KPC cells and combined USP8 inhibitor and αPD-L1 treatment (Fig. 8g).